Global Peripheral Intervention Drug-Eluting Devices Market Growth 2024-2031

Report ID: 1330979 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Peripheral Intervention Drug-Eluting Devices by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Peripheral Intervention Drug-Eluting Devices by Country/Region, 2017, 2022 & 2028
    2.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
        2.2.1 Drug-Eluting Balloons
        2.2.2 Drug-Eluting Stents
    2.3 Peripheral Intervention Drug-Eluting Devices Sales by Type
        2.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2022)
        2.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Type (2017-2022)
    2.4 Peripheral Intervention Drug-Eluting Devices Segment by Application
        2.4.1 Plain Old Balloon Angioplasty (POBA)
        2.4.2 Percutaneous Transluminal Angioplasty (PTA)
    2.5 Peripheral Intervention Drug-Eluting Devices Sales by Application
        2.5.1 Global Peripheral Intervention Drug-Eluting Devices Sale Market Share by Application (2017-2022)
        2.5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Application (2017-2022)
3 Global Peripheral Intervention Drug-Eluting Devices by Company
    3.1 Global Peripheral Intervention Drug-Eluting Devices Breakdown Data by Company
        3.1.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales by Company (2020-2022)
        3.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2020-2022)
    3.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue by Company (2020-2022)
        3.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Company (2020-2022)
        3.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2020-2022)
    3.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Company
    3.4 Key Manufacturers Peripheral Intervention Drug-Eluting Devices Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Peripheral Intervention Drug-Eluting Devices Product Location Distribution
        3.4.2 Players Peripheral Intervention Drug-Eluting Devices Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Peripheral Intervention Drug-Eluting Devices by Geographic Region
    4.1 World Historic Peripheral Intervention Drug-Eluting Devices Market Size by Geographic Region (2017-2022)
        4.1.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue by Geographic Region
    4.2 World Historic Peripheral Intervention Drug-Eluting Devices Market Size by Country/Region (2017-2022)
        4.2.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue by Country/Region
    4.3 Americas Peripheral Intervention Drug-Eluting Devices Sales Growth
    4.4 APAC Peripheral Intervention Drug-Eluting Devices Sales Growth
    4.5 Europe Peripheral Intervention Drug-Eluting Devices Sales Growth
    4.6 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Growth
5 Americas
    5.1 Americas Peripheral Intervention Drug-Eluting Devices Sales by Country
        5.1.1 Americas Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2022)
        5.1.2 Americas Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2022)
    5.2 Americas Peripheral Intervention Drug-Eluting Devices Sales by Type
    5.3 Americas Peripheral Intervention Drug-Eluting Devices Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Peripheral Intervention Drug-Eluting Devices Sales by Region
        6.1.1 APAC Peripheral Intervention Drug-Eluting Devices Sales by Region (2017-2022)
        6.1.2 APAC Peripheral Intervention Drug-Eluting Devices Revenue by Region (2017-2022)
    6.2 APAC Peripheral Intervention Drug-Eluting Devices Sales by Type
    6.3 APAC Peripheral Intervention Drug-Eluting Devices Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Peripheral Intervention Drug-Eluting Devices by Country
        7.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2022)
        7.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2022)
    7.2 Europe Peripheral Intervention Drug-Eluting Devices Sales by Type
    7.3 Europe Peripheral Intervention Drug-Eluting Devices Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices by Country
        8.1.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2022)
    8.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type
    8.3 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Peripheral Intervention Drug-Eluting Devices
    10.3 Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
    10.4 Industry Chain Structure of Peripheral Intervention Drug-Eluting Devices
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Peripheral Intervention Drug-Eluting Devices Distributors
    11.3 Peripheral Intervention Drug-Eluting Devices Customer
12 World Forecast Review for Peripheral Intervention Drug-Eluting Devices by Geographic Region
    12.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Forecast by Region
        12.1.1 Global Peripheral Intervention Drug-Eluting Devices Forecast by Region (2023-2028)
        12.1.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Peripheral Intervention Drug-Eluting Devices Forecast by Type
    12.7 Global Peripheral Intervention Drug-Eluting Devices Forecast by Application
13 Key Players Analysis
    13.1 Medtronic plc
        13.1.1 Medtronic plc Company Information
        13.1.2 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Offered
        13.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Medtronic plc Main Business Overview
        13.1.5 Medtronic plc Latest Developments
    13.2 Boston Scientific Corporation
        13.2.1 Boston Scientific Corporation Company Information
        13.2.2 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Offered
        13.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Boston Scientific Corporation Main Business Overview
        13.2.5 Boston Scientific Corporation Latest Developments
    13.3 Abbott Laboratories
        13.3.1 Abbott Laboratories Company Information
        13.3.2 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Offered
        13.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Abbott Laboratories Main Business Overview
        13.3.5 Abbott Laboratories Latest Developments
    13.4 Cardinal Health
        13.4.1 Cardinal Health Company Information
        13.4.2 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Offered
        13.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Cardinal Health Main Business Overview
        13.4.5 Cardinal Health Latest Developments
    13.5 B. Braun Melsungen AG
        13.5.1 B. Braun Melsungen AG Company Information
        13.5.2 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Offered
        13.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 B. Braun Melsungen AG Main Business Overview
        13.5.5 B. Braun Melsungen AG Latest Developments
    13.6 Biosensors International Group Ltd.
        13.6.1 Biosensors International Group Ltd. Company Information
        13.6.2 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Offered
        13.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Biosensors International Group Ltd. Main Business Overview
        13.6.5 Biosensors International Group Ltd. Latest Developments
    13.7 C.R. Bard, Inc.
        13.7.1 C.R. Bard, Inc. Company Information
        13.7.2 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Offered
        13.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 C.R. Bard, Inc. Main Business Overview
        13.7.5 C.R. Bard, Inc. Latest Developments
    13.8 Abbott
        13.8.1 Abbott Company Information
        13.8.2 Abbott Peripheral Intervention Drug-Eluting Devices Product Offered
        13.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Abbott Main Business Overview
        13.8.5 Abbott Latest Developments
    13.9 The Lubrizol Corporation
        13.9.1 The Lubrizol Corporation Company Information
        13.9.2 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Offered
        13.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 The Lubrizol Corporation Main Business Overview
        13.9.5 The Lubrizol Corporation Latest Developments
    13.10 Terumo Corporation
        13.10.1 Terumo Corporation Company Information
        13.10.2 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Offered
        13.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Terumo Corporation Main Business Overview
        13.10.5 Terumo Corporation Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Peripheral Intervention Drug-Eluting Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Peripheral Intervention Drug-Eluting Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Drug-Eluting Balloons
    Table 4. Major Players of Drug-Eluting Stents
    Table 5. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
    Table 6. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2022)
    Table 7. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2017-2022)
    Table 9. Global Peripheral Intervention Drug-Eluting Devices Sale Price by Type (2017-2022) & (USD/Unit)
    Table 10. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
    Table 11. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
    Table 12. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2022)
    Table 13. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2017-2022)
    Table 14. Global Peripheral Intervention Drug-Eluting Devices Sale Price by Application (2017-2022) & (USD/Unit)
    Table 15. Global Peripheral Intervention Drug-Eluting Devices Sales by Company (2020-2022) & (K Units)
    Table 16. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2020-2022)
    Table 17. Global Peripheral Intervention Drug-Eluting Devices Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2020-2022)
    Table 19. Global Peripheral Intervention Drug-Eluting Devices Sale Price by Company (2020-2022) & (USD/Unit)
    Table 20. Key Manufacturers Peripheral Intervention Drug-Eluting Devices Producing Area Distribution and Sales Area
    Table 21. Players Peripheral Intervention Drug-Eluting Devices Products Offered
    Table 22. Peripheral Intervention Drug-Eluting Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Peripheral Intervention Drug-Eluting Devices Sales by Geographic Region (2017-2022) & (K Units)
    Table 26. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Peripheral Intervention Drug-Eluting Devices Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Peripheral Intervention Drug-Eluting Devices Sales by Country/Region (2017-2022) & (K Units)
    Table 30. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Peripheral Intervention Drug-Eluting Devices Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2022) & (K Units)
    Table 34. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2017-2022)
    Table 35. Americas Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2017-2022)
    Table 37. Americas Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
    Table 38. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2022)
    Table 39. Americas Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
    Table 40. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
    Table 41. APAC Peripheral Intervention Drug-Eluting Devices Sales by Region (2017-2022) & (K Units)
    Table 42. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2017-2022)
    Table 43. APAC Peripheral Intervention Drug-Eluting Devices Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2017-2022)
    Table 45. APAC Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
    Table 46. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2022)
    Table 47. APAC Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
    Table 48. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
    Table 49. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2022) & (K Units)
    Table 50. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2017-2022)
    Table 51. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2017-2022)
    Table 53. Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
    Table 54. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2022)
    Table 55. Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
    Table 56. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2022) & (K Units)
    Table 58. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
    Table 62. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
    Table 64. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Peripheral Intervention Drug-Eluting Devices
    Table 66. Key Market Challenges & Risks of Peripheral Intervention Drug-Eluting Devices
    Table 67. Key Industry Trends of Peripheral Intervention Drug-Eluting Devices
    Table 68. Peripheral Intervention Drug-Eluting Devices Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Peripheral Intervention Drug-Eluting Devices Distributors List
    Table 71. Peripheral Intervention Drug-Eluting Devices Customer List
    Table 72. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Region (2023-2028) & (K Units)
    Table 73. Global Peripheral Intervention Drug-Eluting Devices Sales Market Forecast by Region
    Table 74. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Peripheral Intervention Drug-Eluting Devices Sales Forecast by Country (2023-2028) & (K Units)
    Table 77. Americas Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Peripheral Intervention Drug-Eluting Devices Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. APAC Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Peripheral Intervention Drug-Eluting Devices Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Europe Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2023-2028) & (K Units)
    Table 85. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Medtronic plc Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
    Table 93. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Offered
    Table 94. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 95. Medtronic plc Main Business
    Table 96. Medtronic plc Latest Developments
    Table 97. Boston Scientific Corporation Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
    Table 98. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Offered
    Table 99. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 100. Boston Scientific Corporation Main Business
    Table 101. Boston Scientific Corporation Latest Developments
    Table 102. Abbott Laboratories Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
    Table 103. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Offered
    Table 104. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 105. Abbott Laboratories Main Business
    Table 106. Abbott Laboratories Latest Developments
    Table 107. Cardinal Health Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
    Table 108. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Offered
    Table 109. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 110. Cardinal Health Main Business
    Table 111. Cardinal Health Latest Developments
    Table 112. B. Braun Melsungen AG Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
    Table 113. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Offered
    Table 114. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 115. B. Braun Melsungen AG Main Business
    Table 116. B. Braun Melsungen AG Latest Developments
    Table 117. Biosensors International Group Ltd. Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
    Table 118. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Offered
    Table 119. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 120. Biosensors International Group Ltd. Main Business
    Table 121. Biosensors International Group Ltd. Latest Developments
    Table 122. C.R. Bard, Inc. Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
    Table 123. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Offered
    Table 124. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 125. C.R. Bard, Inc. Main Business
    Table 126. C.R. Bard, Inc. Latest Developments
    Table 127. Abbott Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
    Table 128. Abbott Peripheral Intervention Drug-Eluting Devices Product Offered
    Table 129. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 130. Abbott Main Business
    Table 131. Abbott Latest Developments
    Table 132. The Lubrizol Corporation Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
    Table 133. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Offered
    Table 134. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 135. The Lubrizol Corporation Main Business
    Table 136. The Lubrizol Corporation Latest Developments
    Table 137. Terumo Corporation Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
    Table 138. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Offered
    Table 139. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 140. Terumo Corporation Main Business
    Table 141. Terumo Corporation Latest Developments
List of Figures
    Figure 1. Picture of Peripheral Intervention Drug-Eluting Devices
    Figure 2. Peripheral Intervention Drug-Eluting Devices Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Peripheral Intervention Drug-Eluting Devices Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Peripheral Intervention Drug-Eluting Devices Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Drug-Eluting Balloons
    Figure 10. Product Picture of Drug-Eluting Stents
    Figure 11. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2021
    Figure 12. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2017-2022)
    Figure 13. Peripheral Intervention Drug-Eluting Devices Consumed in Plain Old Balloon Angioplasty (POBA)
    Figure 14. Global Peripheral Intervention Drug-Eluting Devices Market: Plain Old Balloon Angioplasty (POBA) (2017-2022) & (K Units)
    Figure 15. Peripheral Intervention Drug-Eluting Devices Consumed in Percutaneous Transluminal Angioplasty (PTA)
    Figure 16. Global Peripheral Intervention Drug-Eluting Devices Market: Percutaneous Transluminal Angioplasty (PTA) (2017-2022) & (K Units)
    Figure 17. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
    Figure 18. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application in 2021
    Figure 19. Peripheral Intervention Drug-Eluting Devices Revenue Market by Company in 2021 ($ Million)
    Figure 20. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company in 2021
    Figure 21. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Geographic Region (2017-2022)
    Figure 22. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Geographic Region in 2021
    Figure 23. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2017-2022)
    Figure 24. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country/Region in 2021
    Figure 25. Americas Peripheral Intervention Drug-Eluting Devices Sales 2017-2022 (K Units)
    Figure 26. Americas Peripheral Intervention Drug-Eluting Devices Revenue 2017-2022 ($ Millions)
    Figure 27. APAC Peripheral Intervention Drug-Eluting Devices Sales 2017-2022 (K Units)
    Figure 28. APAC Peripheral Intervention Drug-Eluting Devices Revenue 2017-2022 ($ Millions)
    Figure 29. Europe Peripheral Intervention Drug-Eluting Devices Sales 2017-2022 (K Units)
    Figure 30. Europe Peripheral Intervention Drug-Eluting Devices Revenue 2017-2022 ($ Millions)
    Figure 31. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales 2017-2022 (K Units)
    Figure 32. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue 2017-2022 ($ Millions)
    Figure 33. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country in 2021
    Figure 34. Americas Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country in 2021
    Figure 35. United States Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 36. Canada Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Mexico Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Brazil Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 39. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region in 2021
    Figure 40. APAC Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions in 2021
    Figure 41. China Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Japan Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 43. South Korea Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 45. India Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Australia Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country in 2021
    Figure 48. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country in 2021
    Figure 49. Germany Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 50. France Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 51. UK Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Italy Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Russia Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country in 2021
    Figure 55. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country in 2021
    Figure 56. Egypt Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 57. South Africa Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Israel Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Turkey Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 60. GCC Country Peripheral Intervention Drug-Eluting Devices Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Manufacturing Cost Structure Analysis of Peripheral Intervention Drug-Eluting Devices in 2021
    Figure 62. Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
    Figure 63. Industry Chain Structure of Peripheral Intervention Drug-Eluting Devices
    Figure 64. Channels of Distribution
    Figure 65. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Peripheral Intervention Drug-Eluting Devices Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Peripheral Intervention Drug-Eluting Devices Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Peripheral Intervention Drug-Eluting Devices Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports